Gyre Therapeutics, Inc. (GYRE)
(Real Time Quote from BATS)
$14.87 USD
-0.19 (-1.26%)
Updated Jul 25, 2024 10:32 AM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Company Summary
Gyre Therapeutics Inc. is a biotechnology company. It focused on organ fibrosis and inflammatory diseases. The company's product pipeline primarily includes F573, F528 and F230. Gyre Therapeutics Inc., formerly known as Catalyst Biosciences Inc., is based in United States.
Company Summary
General Information
Gyre Therapeutics, Inc
12770 HIGH BLUFF DRIVE SUITE 150
SAN DIEGO, CA 92130
Phone: 619-949-3681
Fax: 336-480-2107
Email: investors@catbio.com
Industry | Medical - Biomedical and Genetics |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 6/30/2024 |
Exp Earnings Date | 8/12/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | NA |
Current Year EPS Consensus Estimate | -0.45 |
Estimated Long-Term EPS Growth Rate | NA |
Exp Earnings Date | 8/12/2024 |